Evidence Synthesis
ELEMARB's standard shift narrative is marked by a significant acceleration in its 53.65%, up from 7.25%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:49
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
ELEMARB's standard shift narrative is marked by a significant acceleration in its 53.65%, up from 7.25%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 53.65 % | 7.25 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 7.25 % | 8.99 | ▼ |
| REVENUE_GROWTH_YOY | 0.3 % | -20.6 | ▲ |
| EPS_ACTUAL | 2.46 INR | — | - |
| EPS_SURPRISE_PERCENT | -0.513 % | — | - |
| PRICE_CHANGE_PERCENT | 3.187 % | — | - |
| DAILY_VOLUME | 48 shares | 316 | ▼ |
| CLOSE_PRICE | 191 INR | 185.1 | ▲ |